← Back to patent-cliff list
CAS 179688-54-1
4-chloro-7-methoxyquinazolin-6-yl acetate hydrochloride
Codes: GEFT-015
Application context (from source-drug indications)
Non-small cell lung cancerGefitinibLung cancerGefitinibHead and neck cancerGefitinibBreast cancerGefitinib唇肿瘤Gefitinib喉肿瘤Gefitinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Gefitinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(3-chloropropyl)morpholine→3-chloro-4-fluoroaniline→6,7-dimethoxyquinazolin-4(3H)-one→L-methionine→6-hydroxy-7-methoxyquinazolin-4(3H)-one→7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate→4-chloro-7-methoxyquinazolin-6-yl acetate hydrochloride→4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate→4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.